CD44 and CD133 aptamer directed nanocarriers for cancer stem cells targeting
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD44 and CD133 aptamer directed nanocarriers for cancer stem cells targeting
Authors
Keywords
-
Journal
EUROPEAN POLYMER JOURNAL
Volume 183, Issue -, Pages 111770
Publisher
Elsevier BV
Online
2022-12-17
DOI
10.1016/j.eurpolymj.2022.111770
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Serum DKK3 and Circulating CD133 Cells as Prognostic Biomarkers for Ovarian Cancer Patients
- (2021) Xiao-Cui Nie et al. OncoTargets and Therapy
- Evaluation of Hippo Pathway and CD133 in Radiation Resistance in Small-Cell Lung Cancer
- (2021) Kui Yang et al. Journal of Oncology
- Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells
- (2021) Shelby B. Smiley et al. PHARMACEUTICAL RESEARCH
- Targeted delivery of doxorubicin through CD44 aptamer to cancer cells
- (2021) Jagadish Natesh et al. Therapeutic Delivery
- Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics
- (2020) Yi Zhong et al. ANALYTICAL BIOCHEMISTRY
- CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway
- (2020) Yang Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Relationships between recurrence patterns and subventricular zone involvement or CD133 expression in glioblastoma
- (2020) Tetsu Yamaki et al. JOURNAL OF NEURO-ONCOLOGY
- Nucleic Acid Aptamers for Molecular Diagnostics and Therapeutics: Advances and Perspectives
- (2020) Weihong Tan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Prognostic significance of branched-chain amino acid transferase 1 and CD133 in triple-negative breast cancer
- (2020) Yu Song et al. BMC CANCER
- Radiotherapy targeting cancer stem cells “awakens” them to induce tumour relapse and metastasis in oral cancer
- (2020) Yangfan Liu et al. International Journal of Oral Science
- Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
- (2020) Shihori Tanabe et al. Frontiers in Pharmacology
- PRRX1 isoform PRRX1A regulates the stemness phenotype and epithelial-mesenchymal transition (EMT) of cancer stem-like cells (CSCs) derived from non-small cell lung cancer (NSCLC)
- (2020) Lei Sun et al. Translational Lung Cancer Research
- Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel
- (2020) Zhen Yu et al. International Journal of Nanomedicine
- EMT, cancer stem cells and autophagy; The three main axes of metastasis
- (2020) Ghader Babaei et al. BIOMEDICINE & PHARMACOTHERAPY
- Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma
- (2020) Siddharth J. Modi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells
- (2020) Gang Zhou et al. CANCER LETTERS
- Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition
- (2019) Yoko Katsuno et al. Science Signaling
- Current approaches in identification and isolation of cancer stem cells
- (2019) Maryam Akbarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells
- (2019) Keke Gui et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer cells stemness: A doorstep to targeted therapy
- (2019) Sahdeo Prasad et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer
- (2019) Tapas Pradhan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133
- (2019) Hongran Yin et al. MOLECULAR THERAPY
- The sustained and targeted treatment of hemangiomas by propranolol-loaded CD133 aptamers conjugated liposomes-in-microspheres
- (2019) Xiaonan Guo et al. BIOMEDICINE & PHARMACOTHERAPY
- Hybrid nanoreservoirs based on dextran‐capped dendritic mesoporous silica nanoparticles for CD133‐targeted drug delivery
- (2019) Mahsa Zahiri et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Characterization of covalent crosslinking strategies for synthesizing DNA-based bioconjugates
- (2019) Malithi P. Wickramathilaka et al. Journal of Biological Engineering
- Proliferative Activity of Colorectal Cancer Cells with Different Levels of CD133 Expression
- (2019) A. M. Gisina et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin
- (2019) Zhiyuan Xu et al. International Journal of Nanomedicine
- Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer
- (2019) Qi Ma et al. Drug Design Development and Therapy
- Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
- (2019) Fadwa Odeh et al. MOLECULES
- OCT4B1 Promoted EMT and Regulated the Self-Renewal of CSCs in CRC: Effects Associated with the Balance of miR-8064/PLK1
- (2019) Jun-min Zhou et al. Molecular Therapy-Oncolytics
- Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers
- (2018) Gang Zhou et al. ADVANCED DRUG DELIVERY REVIEWS
- The roles of CD133 expression in the patients with non-small cell lung cancer
- (2018) Dan Wang et al. Cancer Biomarkers
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Cell-SELEX-Based Identification of a Human and Mouse Cross-Reactive Endothelial Cell-Internalizing Aptamer
- (2018) Pooja Dua et al. Nucleic Acid Therapeutics
- High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance
- (2018) In-geun Ryoo et al. Redox Biology
- Aptamer-based targeted therapy
- (2018) Guizhi Zhu et al. ADVANCED DRUG DELIVERY REVIEWS
- Selection of aptamers against Lactoferrin based on silver enhanced and fluorescence-activated cell sorting
- (2018) Fang Yu et al. TALANTA
- Dimerization of an aptamer generated from Ligand-guided selection (LIGS) yields a high affinity scaffold against B-cells
- (2018) Sana Batool et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development
- (2018) Tao Wang et al. BIOTECHNOLOGY ADVANCES
- Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
- (2018) Chitra Joseph et al. BREAST CANCER RESEARCH AND TREATMENT
- Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity
- (2018) Vineet Kumar Gupta et al. CANCER LETTERS
- The clinicopathological parameters significance of CD133 and Nestin in epithelial ovarian cancer: a meta-analysis
- (2017) Lili Zhao et al. Future Oncology
- Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications
- (2017) Emma Hays et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selection of 2′-Fluoro-Modified Aptamers with Optimized Properties
- (2017) Deepak Thirunavukarasu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens
- (2017) Prabodhika Mallikaratchy MOLECULES
- PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma
- (2017) Xiaonan Guo et al. Nanomedicine
- A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin
- (2017) Yu Gao et al. Nanoscale
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas
- (2017) Elham Kalantari et al. PATHOLOGY & ONCOLOGY RESEARCH
- Modeling Physiological Events in 2D vs. 3D Cell Culture
- (2017) Kayla Duval et al. PHYSIOLOGY
- Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis
- (2017) Zhan Li et al. OncoTargets and Therapy
- Curcumin reversed chronic tobacco smoke exposure induced urocystic EMT and acquisition of cancer stem cells properties via Wnt/β-catenin
- (2017) Zhaofeng Liang et al. Cell Death & Disease
- 3D Cell-SELEX: Development of RNA aptamers as molecular probes for PC-3 tumor cell line
- (2016) Aline G. Souza et al. EXPERIMENTAL CELL RESEARCH
- CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer
- (2016) Zhenbo Tu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting CD44, ABCG2 and CD133 markers using aptamers: in silico analysis of CD133 extracellular domain 2 and its aptamer
- (2016) Nithya Subramanian et al. RSC Advances
- Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX
- (2016) Yifan Lyu et al. Theranostics
- Aptamer–Drug Conjugates
- (2015) Guizhi Zhu et al. BIOCONJUGATE CHEMISTRY
- Long-Term Stabilization of Maleimide–Thiol Conjugates
- (2014) Shaun D. Fontaine et al. BIOCONJUGATE CHEMISTRY
- RNA aptamers targeting cancer stem cell marker CD133
- (2012) Sarah Shigdar et al. CANCER LETTERS
- Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44
- (2010) Anoma Somasunderam et al. BIOCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started